Sunday, July 13, 2014

Hot Life Sciences Companies To Watch For 2014

With shares of General Electric (NYSE:GE) trading around $27, is GE an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

General Electric is a diversified industrial, technology, and financial services company that operates worldwide. The products and services of the company range from aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products. General Electric�� segments are Energy Infrastructure, Aviation, Healthcare, Transportation, Home & Business Solutions, and GE Capital. General Electric is a leading provider of a wide range of products and many are essential in daily lives of consumers and companies around the world.

General Electric on Monday continued its push to expand its healthcare operation, agreeing to acquire certain life science assets of Thermo Fisher Scientific for $1.06 billion in cash.�The deal includes Waltham, Mass.-based Thermo Fisher’s cell culture, gene modulation, and magnetic bead businesses. The units, part of Thermo Fisher’s analytical technologies segment, generated combined revenue of about $250 million in 2013.�Fairfield, Conn.-based GE has been seeking to refocus its sprawling collection of businesses since the economic downturn, and looking to divest its consumer finance operations and to grow in healthcare and energy. The company said the Thermo Fisher units would be folded into its $4 billion-sales GE Healthcare life sciences business, giving it a more complete portfolio of tools used for cell biology research, cell therapy and for the manufacture of new biological medicines and vaccines.

Best Freight Stocks To Own For 2015: Dana Holding Corporation (DAN)

Dana Holding Corporation engages in the design, manufacture, and supply of driveline products, technologies, and service parts for vehicle manufacturers worldwide. The company operates in four segments: Vehicle Driveline Technologies, Commercial Vehicle Driveline Technologies, Off-Highway Driveline Technologies, and Power Technologies. It provides light axles, driveshafts, engine sealing products, thermal products, and related service parts for light trucks, sport utility vehicles, crossover utility vehicles, vans, and passenger cars. The company also offers axles, driveshafts, chassis and side rails, ride controls and related modules and systems, engine sealing products, thermal products, and related service parts for medium- and heavy-duty trucks, buses, and other commercial vehicles. In addition, it provides axles, driveshafts, suspension components, transmissions, electronic controls, related modules and systems, engine sealing products, thermal products, and related s ervice parts for construction and earth moving machinery; agricultural, mining, forestry, rail, and material handling equipment; and various non-vehicular and industrial applications. Dana Holding Corporation was founded in 1904 and is headquartered in Maumee, Ohio.

Advisors' Opinion:
  • [By Rich Duprey]

    Auto components manufacturer Dana Holding� (NYSE: DAN  ) announced yesterday its third-quarter dividend of $0.05 per share, the same rate it's paid since it began making a payout last year. The board of directors said the quarterly dividend is payable on Aug. 30 to the holders of record at the close of business on Aug. 9.�

  • [By WWW.GURUFOCUS.COM]

    Dana Holding Corp. (DAN)(0.3%) (DAN - $23.27 - NYSE) is a Maumee, Ohio based supplier of axles, drivelines and thermal products for the automotive and trucking industries. Dana's new CEO, Roger Wood, has begun to emphasize the company's strong technological expertise in thermal management technology, including advanced battery cooling products for next generation vehicles. Additionally, the company is beginning to reap the benefits of efforts to improve customer pricing as well as internal manufacturing efficiencies, both of which are expected to improve margins amid robust demand in the company's core auto and trucking markets.From Mario Gabelli (Trades, Portfolio)'s Gabelli Asset Fund's first quarter 2014 shareholder commentary.Also check out: Mario Gabelli Undervalued Stocks Mario Gabelli Top Growth Companies Mario Gabelli High Yield stocks, and Stocks that Mario Gabelli keeps buying Currently 0.00/512345

    Rating: 0.0/5 (0 votes)

Hot Life Sciences Companies To Watch For 2014: Virgin Australia Holdings Ltd (VBHLF)

Virgin Australia Holdings Limited (VAH) is an Australia-based company engaged in the development and operation of domestic and international airlines. VAH�� fleet includes ATR-72, Embraer 190, Boeing 737-700, Boeing 737-800, AIRBUS A330 and Boeing 777-300ER. It product includes Airbus A330 Business Class. During the fiscal year ended June 30, 2012, the Company carried 19,468,929 guests on 216 city pairs to 52 destinations, and operated 162,817 flights. On February 22, 2012, under the proposal, all of the shares in the international airline business of Virgin Australia were transferred to a new holding company, Virgin Australia International Holdings Pty Ltd. In April 2013, it acquired 100% of the issued share capital in Skywest Airlines Ltd. In July 2013, Virgin Australia Holdings Limited announced that it has acquired 60% interest of Tiger Airways Australia Pty Limited from Tiger Airways Holdings Limited. Advisors' Opinion:
  • [By MARKETWATCH]

    LOS ANGELES (MarketWatch) -- Australian stocks gave ground in early Friday trading, with banks broadly lower after overnight losses in the U.S., where investors worried that better-than-expected data would prompt the Federal Reserve to roll back stimulus soon. The S&P/ASX 200 (AU:XJO) lost 0.4% to 5,178.30, as National Australia Bank Ltd. (AU:NAB) (NAUBF) fell 1.8%, Australia & New Zealand Banking Group (AU:ANZ) (ANEWF) lost 0.8%, and Macquarie Group Ltd. (AU:MQG) (MCQEF) retreated 1.3%. Among the resource shares, losses for gold both in New York and in early Asian electronic trade helped send Evolution Mining Ltd. (AU:EVN) (CAHPF) down 1.9% and Kingsgate Consolidated Ltd. (AU:KCN) (KSKGF) off 4.5%, though Newcrest Mining Ltd. (AU:NCM) (NCMGF) held the drop to 0.4%. Oil prices managed a modest gain, however, resulting in a 0.2% rise for Oil Search Ltd. (AU:OSH) (OISHF) and Karoon Gas Australia Ltd. (AU:KAR) (KRNGF) , while Woodside Petroleum Ltd. (AU:WPL)

Hot Life Sciences Companies To Watch For 2014: Dejour Energy Inc (DEJ)

Dejour Energy Inc. is engaged in the business of acquiring, exploring and developing energy projects with a focus on oil and gas exploration in Canada and the United States. The Company holds approximately 113,000 net acres of oil and gas leases in the Peace River Arch of northwestern British Columbia and northeastern Alberta, Canada and the Piceance, Paradox and Uinta Basins in the United States Rocky Mountains. The Company has 71.43% working interest in this 3,014 acre (gross) project located south of Roan Creek. The Company also has 71.43% working interest in this 18,000 acre (gross) project located north of the Rangely Field, is prospective for oil in the Lower Mancos (Niobrara), Dakota, Morrison and Phosphoria formations. Advisors' Opinion:
  • [By CRWE]

    Vancouver, BC, Dec. 16, 2013 — (CRWE Press Release) — Dejour Energy Inc. (NYSE MKT:DEJ) (TSX:DEJ), an independent oil and natural gas exploration and production company operating in North America’s Piceance Basin and Peace River Arch regions, today announces that it has signed a Letter of Intent to create a strategic joint venture partnership with a private Singapore based energy company (��ECO�� to develop the company�� Colorado oil and gas assets.

    Upon completion of due diligence, legal documentation and requisite approvals expected prior to January 31, 2014, SECO will invest an initial sum of up to $27.5mm in 2014 and 2015 to earn an 85% share in Dejour�� interests in its Colorado properties, primarily Kokopelli, subject to certain interest claw backs available to Dejour. Following this capital investment by SECO, the partners will continue to judiciously develop the reserves on a pro rata basis.

    The terms of the agreement include a capital injection to Dejour of approximately US$ 4.5mm, including cash and assumption of certain liability agreements on outstanding debt and the 100% development funding of an initial $10.5mm in capital expenditures in 2014 with a further $12mm in 2015, targeting Kokopelli, subject to certain provisions. Additionally, SECO will assume 85% of the ongoing overhead of Dejour�� U.S. operations and joint project management during the initial period. SECO will also share responsibility to maintain the other Dejour U.S. leases in good standing on a pro rata ownership basis or return them to Dejour in a timely fashion. Dejour will remain the operator of record.

    ��ECO shares Dejour�� value proposition relating to the company�� U.S. E&P portfolio. This partnership will bring many strategic advantages to Dejour: minimizing capital requirement in the short term, bolstering the company�� balance sheet and long term US cash flow, the provision of flexibility for Dejour to pursue new

Hot Life Sciences Companies To Watch For 2014: Knoll Inc (KNL)

Knoll, Inc., incorporated on December 15, 1995, is a designer and manufacturer of workplace furnishings, textiles and fine leathers. The Company operates in three segments: Office, Studio and Coverings. The Office segment includes systems, seating, storage, tables, desks and KnollExtra ergonomic accessories, as well as the international sales of the Company's North American Office products. The Studio segment includes the Company's KnollStudio division, the Company's European subsidiaries, which primarily sell KnollStudio products, and Richard Schultz Design. The KnollStudio portfolio includes a range of lounge seating, side, cafe and dining chairs, barstools, and conference, dining and occasional tables. Richard Schultz Design provides outdoor furniture. The Coverings segment includes KnollTextiles, Spinneybeck (including Filzfelt), and Edelman Leather. In February 2014, Knoll Inc completed the acquisition of Holly Hunt Enterprises, Inc.

Office Segment

The Company�� systems furniture consists principally of functionally integrated panels or table desks, work surfaces, pedestal and other storage units, power and data systems and lighting. The Company's systems furniture product lines include panel and desk-based planning models, which consists of Antenna Workspaces, Reff Profiles, AutoStrada, Dividends Horizon, Morrison, Equity and Currents. The Company�� principal seating product lines include generation by Knoll, ReGeneration by Knoll, LIFE, RPM and Chadwick. Essentials Work Chairs' Pro, Tech, and Sport models offer a range of four task and two side chairs suitable to any office style from the traditional to the progressive. The Company�� files and storage products, featuring the Template, Calibre and Series 2 product lines, are designed with features to maximize storage capabilities throughout the workplace.

The Company�� core files and storage products consist of lateral files, mobile pedestals and other storage units, bookcases and overhead storage ! cabinets.. The Company offers collections of adjustable tables, as well as meeting, conference, training, dining, and cafe tables for large scale projects and standalone desks and table desks. The Company's Interaction and Upstart product lines include adjustable, work, meeting, conference and training tables. These product lines range from independent tables to tables suitable for workstations that support individual preferences for computer and writing heights to plannable desks that can be linked together to build and reshape larger work areas. KnollExtra offers accessories that complement Knoll office furniture products, including technology support accessories, desktop organizational tools, lighting and storage.

Studio Segment

The KnollStudio portfolio includes a range of lounge seating; side, cafe and dining chairs, barstools, and conference, dining and occasional tables. The Company�� studio segment includes the Knoll Europe businesses. Knoll Europe provides products and services primarily to its European clients, whose aesthetics and styles can be different from its North America clients. A majority of Knoll Europe's business is Knoll Studio products, but Knoll Europe also offers a product profile that enables its customers to purchase a complete office environment. In addition, it offers certain products designed specifically for the European market. In Europe, the core product categories include KnollStudio, desk systems, including the Wa desking system, the KnollScope, and the PL1 system, seating, including a range of chairs, and storage units, which are designed to complement Knoll desk products. During 2012, it acquired Richard Schultz Design, Inc., a designer and manufacturer of outdoor furniture for the residential, hospitality, and contract office furniture markets.

Coverings Segment

The Company's Coverings segment consists of KnollTextiles, Spinneybeck Leather (including Filzfelt products), and Edelman Leather. KnollTextiles offers u! pholstery,! panel fabrics, wallcoverings and drapery that harmonize color, pattern and texture and offers products for corporate, hospitality, healthcare and residential interiors. KnollTextiles products are used in the manufacture of Knoll furniture and are sold to clients for use in other manufacturers' products. Spinneybeck Enterprises, Inc., (Spinneybeck), the Company's wholly owned subsidiary, offers leathers and related products, including leather rugs and wall panels. Spinneybeck supplies upholstery leather for use on Knoll furniture and for sale directly to clients, including other office furniture manufacturers, upholsterers, aviation, custom coach and boating manufacturers. Edelman Leather LLC, (Edelman) its wholly owned subsidiary, supplies fine leathers to residential, hospitality, aviation and contract office furniture markets. Edelman, offers a residential showroom network where designers and retail consumers can sample its products.

The Company competes with Herman Miller, Inc., Steelcase, Inc., Haworth, Inc., HNI Corporation and Teknion Corporation.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Knoll (NYSE: KNL  ) , whose recent revenue and earnings are plotted below.

Hot Life Sciences Companies To Watch For 2014: Horizon Pharma Inc (HZNP)

Horizon Pharma, Inc. (Horizon), incorporated on March 23, 2010, is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. On April 23, 2011, the United States Food and Drug Administration, approved DUEXIS (formerly HZT-501), a tablet formulation containing a fixed-dose combination of ibuprofen and famotidine in a single pill. The Company�� other product, LODOTRA (NP-01), is a programmed release formulation of low-dose prednisone that is marketed in Europe by the Company�� distribution partner, Mundipharma International Corporation Limited (Mundipharma). As of December 31, 2010, Horizon completed multiple Phase III clinical trials of LODOTRA. In addition to these product candidates, the Company has a pipeline of earlier-stage product candidates to treat pain-related diseases and chronic inflammation. On April 1, 2010, Horizon effected a recapitalization and acquisition pursuant to which Horizon Pharma, Inc. became a holding company, that operates through its wholly owned subsidiaries, Horizon Pharma USA, Inc. (formerly Horizon Therapeutics, Inc.) and Horizon Pharma AG (formerly Nitec Pharma AG (Nitec)).

DUEXIS

DUEXIS is a combination of 800 milligram ibuprofen and 26.6 milligram famotidine in a single pill and is indicated for the relief of signs and symptoms of rheumatoid arthritis (RA), and osteoarthritis (OA), and to decrease the risk of developing upper gastrointestinal (GI), ulcers in patients who are taking ibuprofen for those indications. The Company has completed two Phase III clinical trials in a total of over 1,500 patients with mild to moderate pain or arthritis that demonstrated a significant reduction in the incidence of non-steroidal anti-inflammatory drugs (NSAID)-induced upper GI ulcers when treated with DUEXIS versus ibuprofen alone.

LODOTRA

LODOTRA is a programmed release formulation of low-dose prednisone, a well-established drug use! d to inhibit the production of various pro-inflammatory cytokines, which are proteins associated with joint inflammation in RA. LODOTRA has received regulatory approval in Europe for the treatment of moderate to severe, active RA in adults when accompanied by morning stiffness. As of December 31, 2010, the Company had completed two pivotal Phase III clinical trials of LODOTRA in a total of over 600 patients with RA. The first pivotal Phase III trial supported the approval of LODOTRA in Europe in March 2009, where it is approved for marketing in 14 European countries. LODOTRA achieved significant results and met the primary endpoint in each of the two pivotal Phase III clinical trials. Its LODOTRA product was developed and is owned by Horizon Pharma AG. As of December 31, 2010, the Company markets LODOTRA in Europe through three separate agreements. Pursuant to two separate agreements, it granted Merck Serono GmbH and Merck GesmbH, an affiliate of Merck Serono, the rights to distribute and market LODOTRA in each of Germany and Austria, respectively, and pursuant to the third agreement, it granted Mundipharma rights to distribute and market LODOTRA in the rest of Europe. The Company also has a manufacturing and supply agreement with Jagotec AG under which Jagotec or its affiliates manufacture and supply LODOTRA to the Company as bulk tablets.

The Company competes with Pfizer Inc., Pozen Inc., Abbott Laboratories and Amgen Inc.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Top losers in the sector included Horizon Pharma (NASDAQ: HZNP), off 9.5 percent, and Anacor Pharmaceuticals (NASDAQ: ANAC), down 8.2 percent.

    Top Headline
    The Greenbrier Companies (NYSE: GBX) reported a 13% gain in its fiscal second-quarter earnings. Greenbrier's quarterly profit surged to $15.6 million, or $0.50 per share, versus a year-ago profit of $13.8 million, or $0.45 per share. Excluding one-time items, it earned $0.51 per share. Its revenue climbed 88% to $502.2 million. However, analysts were expecting earnings of $0.60 per share on revenue of $508.69 million.

Hot Life Sciences Companies To Watch For 2014: ProAssurance Corporation(PRA)

ProAssurance Corporation, through its subsidiaries, provides medical and other professional liability insurance products to health care service, legal service, and other professional service providers in the United States. It primarily offers its products to physicians, dentists, chiropractors, optometrists, and allied health professionals. The company markets its products through an internal sales force, as well as independent agents. ProAssurance Corporation was founded in 1976 and is based in Birmingham, Alabama.

Advisors' Opinion:
  • [By Rich Duprey]

    Specialty insurance company�ProAssurance� (NYSE: PRA  ) �announced yesterday�its second-quarter dividend of $0.25 per share, the same rate it's paid since it initiated a payout in 2011.

  • [By Lauren Pollock]

    ProAssurance Corp.(PRA) agreed to acquire Eastern Insurance Holdings Inc.(EIHI) for about $205 million, expanding the insurance company’s casualty insurance offerings. Eastern Insurance is a domestic casualty insurance group specializing in workers’ compensation products and services, among other things. ProAssurance plans to pay $24.50 in cash for each outstanding Eastern share, a 16% premium over Monday’s closing price.

Hot Life Sciences Companies To Watch For 2014: Burlington Stores Inc (BURL)

Burlington Stores, Inc., incorporated on February 13, 2013, is a national off-price retailer of branded apparel, operating 503 stores, inclusive of an Internet store, in 44 states and Puerto Rico. The Company offers its merchandise using an Every Day Low Price (EDLP) model with savings up to 60-70% off department and specialty store regular prices. It provides its customers with a selection of fashionable branded product in women�� ready-to-wear apparel, menswear, youth apparel, baby products, footwear, accessories, home goods and coats. The Company merchandise from over 3,500 vendors, with a focus on nationally-recognized brands. This vendor breadth provides its customers with a treasure hunt experience of searching for great brands at great value.

The Company�� average store size is approximately 80,000 square feet, which is two to three times the size of its off-price competitors��stores. Its larger store size has allowed the Company to offer more categories and substantially more breadth in each product category than its off-price competitors and to establish ourselves as a destination for select categories, including coats, youth and baby, special-occasion dresses and men�� tailored apparel.

Advisors' Opinion:
  • [By Paul Ausick]

    Ross Stores Inc. (NASDAQ: ROST) has said that its more than 1,100 stores will remain closed on Thanksgiving, as has The TJX Companies Inc. (NYSE: TJX), owner of the TJ Maxx, Marshall��, and other retail brands. Another off-price retailer, Burlington Stores Inc. (NYSE: BURL), owner of the Burlington Coat Factory stores, will also remain closed on the holiday.

  • [By John Kell and Tess Stynes var popups = dojo.query(".socialByline .popC"); p]

    Among the companies expected to actively trade in Thursday’s session are Burlington Stores Inc.(BURL), ConAgra Foods Inc.(CAG) and Guess Inc.(GES)

No comments:

Post a Comment